Plain-English translation of NCT06122896 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Pancreatic Cancer research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This research study is testing whether combining blood-based tests with standard imaging procedures—like ultrasound or MRI—can catch pancreatic cancer earlier in people at high risk. Researchers will follow you over time to see if these screening methods can detect cancer at a stage when treatment may be more effective.
Pancreatic cancer is often found too late for effective treatment. This trial exists to see if regular screening can catch the disease much earlier in people who are genetically predisposed or have a family history of pancreatic cancer, potentially saving lives.
You likely qualify if…
You likely don't qualify if…
You will have an initial visit where you complete questionnaires and undergo blood tests along with an imaging scan of your pancreas. After that, you will return every 6 months for blood tests and questionnaires, and every 12 months for repeat imaging scans and stool and saliva sample collection. The study lasts at least 2.5 years but can continue for up to 20 years with annual follow-up visits and sample collection.
AI-generated summary from trial data · Jul 6, 2026 · Not medical advice
United States